**Core Concept**
The question requires knowledge of **pharmacokinetics** and **drug elimination**, particularly in patients with **hepatic** and **renal failure**. Understanding how drugs are metabolized and excreted is crucial in this context.

**Why the Correct Answer is Right**
Since the correct answer is not specified, let's consider a general approach. A drug that can be used in both hepatic and renal failure would ideally have a **non-renal, non-hepatic** route of elimination or be **dialyzable**. This would allow for safe use without significant accumulation due to impaired metabolism or excretion.

**Why Each Wrong Option is Incorrect**
**Option A:** Without knowing the specific option, we can say that an incorrect choice might be a drug that is primarily **hepatatically metabolized** or **renally excreted**, making it unsuitable for patients with failure of these organs.
**Option B:** Similarly, this might be a drug with a **narrow therapeutic index** and significant **hepatic** or **renal** elimination, posing a risk in patients with organ failure.
**Option C:** This could be a drug that, despite being useful in one type of organ failure, has limitations in the other, such as **hepatic dosage adjustments** being insufficient to manage **renal failure** safely.
**Option D:** Assuming this is not the correct answer, it might be a drug that is **contraindicated** in either **hepatic** or **renal failure**, or both, due to its pharmacokinetic profile.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that **dosing adjustments** are critical in patients with organ failure. Understanding the **pharmacokinetics** of drugs, including their metabolism and excretion, is essential for safe prescribing in these patients.

**Correct Answer:** Unfortunately, without the actual options provided, a specific correct answer cannot be given.